Differential expression of estrogen receptor mRNA splice variants in the tamoxifen resistant human breast cancer cell line, MCF-7/TAMR-1 compared to the parental MCF-7 cell line
- 1 April 1995
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 109 (2) , 197-207
- https://doi.org/10.1016/0303-7207(95)03503-y
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Antiestrogens Activate an Estrogen Receptor Mutant Exhibiting Enhanced Binding to the Estrogen Response ElementBiochemical and Biophysical Research Communications, 1994
- A highly conserved region in the hormone-binding domain of the human estrogen receptor functions as an efficient transactivation domain in yeastGene, 1994
- Functional analysis of an alternatively spliced estrogen receptor lacking exon 4 isolated from MCF-7 breast cancer cells and meningioma tissueMolecular and Cellular Endocrinology, 1994
- Molecular mechanisms of antiestrogen action in breast cancerBreast Cancer Research and Treatment, 1994
- Expression of estrogen receptor variantsJournal of Cellular Biochemistry, 1993
- Point mutation of estrogen receptor (ER) in the ligand-binding domain changes the pharmacology of antiestrogens in ER-negative breast cancer cells stably expressing complementary DNAs for ERMolecular Endocrinology, 1992
- Effect of Estrogen and Antiestrogens on Cell Proliferation and Synthesis of Secreted Proteins in the Human Breast Cancer Cell Line MCF-7 and a Tamoxifen Resistant Variant Subline, AL-1Acta Oncologica, 1992
- Antiestrogen Resistance: Mechanisms by Which Breast Cancer Cells Undermine the Effectiveness of Endocrine TherapyJNCI Journal of the National Cancer Institute, 1991
- Genomic DNA analysis of the estrogen receptor gene in breast cancerBreast Cancer Research and Treatment, 1989
- Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-ANature, 1986